Roll over image to zoom in
Mounjaro
$160.00$169.00 (-5%)
| Price | From £169 / Month |
| How it works | Suppresses appetite |
| Effectiveness | 16-22.5% loss depending on the dose |
| Eligibility | BMI over 30, or over 27 with a weight-related condition, such as high blood pressure or high cholesterol |
| Side effects | Common side effects include fatigue, dizziness, nausea |
| Dosage |
Starting at 2.5mg ONCE weekly.
Titrating up by 2.5mg each month.
Maximum dosage of 15mg ONCE weekly.
|
Mounjaro is a highly effective, UK licensed weight loss treatment. It has been shown in clinical trials to help achieve up to 22.5% body weight loss. It is the latest GLP-1 weight loss medication, and is used for people with a body mass index (BMI) over 30. It can also be prescribed for patients with a BMI of 27+ and a weight-related medical condition, such as high blood pressure or high cholesterol.
The active ingredient tirzepatide is a registered trademark of Eli Lilly.
It is known as Zepbound in the US, but launched in the UK under the brand name Mounjaro.
It is used ONCE weekly, as a subcutaneous (under the skin) injection.
Mounjaro weight loss pens mimic the action of GLP-1, a natural hormone produced in the gut. This innovative treatment promotes significant weight loss for patients by acting similarly to GLP-1. Its two main effects are;
- It helps regulate appetite, making it easier to eat less
- It makes you feel fuller for longer
Both actions lead to eating fewer calories, which results in weight loss. Focusing on a reduced-calorie diet can amplify the benefits.
Reviews
There are no reviews yet.